← Insider buys
RVNC

Revance Therapeutics, Inc.

President Dustin S Sjuts sold $726K of Revance Therapeutics, Inc.

Sold$726,003
$34.55Price
21,015Shares
−12%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, May 15. Filed Tue, May 16, 4:29 PM ET, after the close. Not investment advice.